Workers’ Comp Claims Still Ignore Mental Health, and Costs Follow

The Hidden Mental Health Thread in Workers’ Comp

Workers’ compensation has long been organized around the physical injury, but a white paper from claims administrator Broadspire argues that mental health is one of the most influential and least addressed factors in how a claim resolves. Anxiety, depression, fear of reinjury and financial strain can all slow recovery and return to work, yet many organizations still react to psychological issues only after they have already extended claim duration and driven up costs.

The paper points to the opioid epidemic as a compounding factor. Injured workers who may have a pre-existing mental health condition are sometimes prescribed addictive opioid medications, develop dependence, and face a longer, more expensive recovery. A 2024 report published in New Solutions: A Journal of Environmental and Occupational Policy, cited by Broadspire, indicates that the process of applying for and receiving workers’ compensation benefits can itself create psychological problems that were not documented before the injury.

That makes early identification of psychosocial risk more than a clinical nicety: Broadspire says addressing those risks early has the potential to reduce both claim duration and costs. The paper’s central criticism is that few organizations have restructured their claims processes to do this proactively.

Why Early Psychosocial Intervention Is Harder Than It Sounds

The gap between awareness and process change

Broadspire’s argument is not that employers deny the relevance of mental health; it is that acknowledgement has not translated into operational change. Many claims systems remain built around physical diagnosis codes, treatment plans and return-to-work dates, meaning psychosocial barriers are discovered late. By the time anxiety or depression is recognized, the claim has often already accumulated additional medical appointments, lost work time and case-management effort.

Why the opioid link makes early screening matter

The white paper connects mental health and opioid prescribing in a specific sequence: a worker with an unrecognized pre-existing mental health condition may be more vulnerable when prescribed addictive painkillers. Once dependency develops, the claim becomes longer, costlier and harder to resolve. That sequence makes psychological screening a cost-control tool as well as a care issue.

The claims process itself can be a source of harm

The 2024 New Solutions report cited in the paper suggests the workers’ compensation process can generate new psychological issues. Disputes, delays, loss of identity and uncertainty about returning to a previous job can worsen a worker’s mental state. If the system itself can create or amplify psychosocial risk, leaving that risk unmanaged may be extending claims even when the original physical injury is stable.

For Claims Leaders: Turning Early Screening Into Lower Durations

For claims organizations, self-insured employers and workers’ compensation teams, the white paper’s argument points to several operational changes, each tied to the duration and cost drivers it names.

• Add psychosocial screening at first notice of loss. Because the paper says early intervention can reduce duration and costs, flag claims with pre-existing mental health conditions, high opioid-risk characteristics or long expected recovery timelines before the first treatment decision is made.
• Review opioid prescribing protocols when mental health history is present. The paper links pre-existing mental health conditions to opioid dependency; ensure adjusters and nurse case managers check for that history before monitoring or approving an opioid prescription.
• Audit the claims journey itself for psychological stressors. Since the cited 2024 report says the benefits process can create psychological issues, map application, communication and return-to-work steps to remove unnecessary delays and uncertainty that may prolong claims.
• Pilot integrated mental health support on long-duration claims and measure the result. Broadspire asserts cost and duration savings but the summary does not provide public data; tracking baseline duration and medical cost before and after a screening pilot would test the claim against your own book of business.